Has COVID-19 made paying for your medicine a challenge? AbbVie may be able to help. Call 1.800.4HUMIRA or tapclick to learn more
Learn about the role inflammation plays in your disease, and how HUMIRA targets a key source of eye inflammation. Plus, learn why a rheumatologist may work together with your eye doctor to treat your condition.
*HUMIRA (adalimumab) is approved for the treatment of non-infectious intermediate, posterior, and panuveitis in adults and children 2 years of age and older.